GGrantIndex
← Leaderboards

Katsumi Kitagawa

St. Jude Children'S Research Hospital

$4,441,387
Attributed
$4,441,387
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $566.5K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,441,387 · 6

By mechanism

R01$3,648,699 · 2
R21$788,479 · 2
P41$4,209 · 2

Top collaborators

No co-investigators on record.

Most similar at St. Jude Children'S Research Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Centromere

Research focus

CentromereCellsKinetochoresChromosome SegregationChromosomesMitosisChromatinProteinsMicrotubulesMutationSignal TransductionStructureCell CycleMalignant NeoplasmsMitoticPlayMutantHistone H3Centromere Protein AMolecularVariantBiochemicalPhenotypeEnsure

Grant awards (21)

The role of EWSR1 at the centromere$310,000
R01 · FY2025 · GM · contact PI
The role of EWSR1 at the centromere$310,000
R01 · FY2024 · GM · contact PI
THE ROLE OF EWSRI AT CENTROMERE-$199,523
R01 · FY2024 · GM · contact PI
The role of EWSR1 at the centromere--$56,953
R01 · FY2024 · GM · contact PI
The role of EWSR1 at the centromere$310,000
R01 · FY2023 · GM · contact PI
The role of CENP-A in the response to DNA double-strand breaks$232,500
R21 · FY2023 · ES · contact PI
The role of CENP-A in the response to DNA double-strand breaks$193,750
R21 · FY2022 · ES · contact PI
Formation of Neocentromere at a DSB Site$199,013
R21 · FY2017 · CA · contact PI
Formation of Neocentromere at a DSB Site$89,382
R21 · FY2016 · CA · contact PI
Formation of a Neocentromere at a DSB Site$73,834
R21 · FY2016 · CA · contact PI
Kinetochore Function and Cell Cycle Progression Revision$275,213
R01 · FY2012 · GM · contact PI
Kinetochore Function and Cell Cycle Progression Revision$275,213
R01 · FY2011 · GM · contact PI
Kinetochore Function and Cell Cycle Progression Revision$277,992
R01 · FY2010 · GM · contact PI
Kinetochore Function and Cell Cycle Progression Revision$327,600
R01 · FY2009 · GM · contact PI
Kinetochore Function and Cell Cycle Progression$248,898
R01 · FY2007 · GM · contact PI
CIMA (CASPASE-INDEPENDENT MITOTIC APOPTOSIS)$2,170
P41 · FY2007 · RR · contact PI
Kinetochore Function and Cell Cycle Progression$256,332
R01 · FY2006 · GM · contact PI
CIMA (CASPASE-INDEPENDENT MITOTIC APOPTOSIS)$2,039
P41 · FY2006 · RR · contact PI
Kinetochore Function and Cell Cycle Progression$262,500
R01 · FY2005 · GM
Kinetochore Function and Cell Cycle Progression$262,500
R01 · FY2004 · GM
Kinetochore Function and Cell Cycle Progression$275,975
R01 · FY2003 · GM